Fineline Cube

Follow:
14475 Articles
Sanofi Secures EU Conditional Approval for Rezurock in Chronic Graft-Versus-Host Disease
CompanyDrug

Sanofi Secures EU Conditional Approval for Rezurock in Chronic Graft-Versus-Host Disease

CompanyDeals

Gilead and Galapagos Forge $2.175 Billion T-Cell Engager Collaboration for Autoimmune Diseases Following Ouro Medicines Acquisition

CompanyDeals

Merck & Co. Partners with Infinimmune for $838 Million Antibody Discovery Collaboration Using Human-First Platform

Biogen Secures FDA Approval for High-Dose Spinraza Regimen in Spinal Muscular Atrophy
CompanyDrug

Biogen Secures FDA Approval for High-Dose Spinraza Regimen in Spinal Muscular Atrophy

CompanyDrug

AstraZeneca Reports Positive Phase III Results for Efzimfotase Alfa in Hypophosphatasia Across Pediatric and Adult Populations

CompanyDeals

Otsuka Pharmaceutical to Acquire Transcend Therapeutics for Up to $1.225 Billion to Expand Neuropsychiatric Pipeline

Novo Nordisk Launches Wegovy Subscription Program to Improve Obesity Treatment Access and Affordability
CompanyDrug

Novo Nordisk Launches Wegovy Subscription Program to Improve Obesity Treatment Access and Affordability

Gan & Lee Pharmaceuticals' Once-Weekly Insulin GZR4 Demonstrates Superior HbA1c Reduction in Phase III Trials
CompanyDrug

Gan & Lee Pharmaceuticals’ Once-Weekly Insulin GZR4 Demonstrates Superior HbA1c Reduction in Phase III Trials

CompanyDrug

Abbisko Therapeutics Secures EMA Orphan Drug Designation for Irpagratinib in Hepatocellular Carcinoma

MicroPort Scientific Returns to Profitability as Global Access Platform Drives 78.8% Revenue Surge
Company

MicroPort Scientific Returns to Profitability as Global Access Platform Drives 78.8% Revenue Surge

CompanyMedical Device

Amoy Diagnostics and HutchMed Secure World’s First NMPA Approval for MET Amplification Companion Diagnostic

CompanyDeals

Abbott Integrates Precision Oncology Portfolio into Flatiron’s OncoEMR Platform to Streamline Cancer Care